# President & CEO AG

- **Section**: news
- **Answer**: President & CEO AG: 23 headlines on record, 0 headlines in the last 90 days.
- **As of**: 2026-11-18
- **Cite**: President & CEO AG, News. Alion, Nov 18, 2026. https://alion.io/company/alliancerm/news
- **License**: CC BY-SA 4.0

## Company

- **Id**: 1898238
- **Name**: President & CEO AG
- **Domain**: alliancerm.org
- **Url**: <https://alion.io/company/alliancerm>

## Figures

- Label: Headlines; Value: 23
- Label: In 90 days; Value: 0
- Label: Milestones; Value: 0

## Blocks

- **Headlines** — Key: news; Source: the outlets named on each headline, each story once; Rows: 22

## News

- [FDA takes major step to ease access to CAR-T therapy](https://biopharmadive.com/news/car-t-rems-fda-ease-requirements-bcma-cd19/751865/) — Date: 2025-06-27; Kind: News; Source: BioPharmaDive
- [Gene therapy faces fresh uncertainty as two more top FDA officials depart](https://biopharmadive.com/news/nicole-verdun-rachael-anatol-fda-leave-gene-therapy/751156/) — Date: 2025-06-20; Kind: News; Source: BioPharmaDive
- [HHS Secretary Favors Regenerative Medicine Over Traditional Pharma: Blessing And Curse?](https://insights.citeline.com/pink-sheet/advanced-technologies/cell-and-gene-therapies/hhs-secretary-favors-regenerative-medicine-over-traditional-pharma-blessing-and-curse-J347KC7XHREKTPMTBX5WTF6AAM/) — Date: 2025-06-10; Kind: News; Source: Insights
- [Scientific societies call for a moratorium on using CRISPR to create genetically modified children](https://statnews.com/2025/05/13/scientific-societies-call-for-ten-year-moratorium-on-germline-gene-editing-crispr/) — Date: 2025-05-13; Kind: News; Source: STAT
- [EU HTA Regulation: 'Stepping Beyond' JCAs May Be Needed For Very Rare Disease Drugs](https://insights.citeline.com/pink-sheet/conferences/eu-hta-regulation-stepping-beyond-jcas-may-be-needed-for-very-rare-disease-drugs-TRAKH6MLJNADXLUEQJYXRVQBOE/) — Date: 2025-05-06; Kind: News; Source: Insights
- [What The EMA Can Teach HTA Bodies About Joint Clinical Assessments](https://insights.citeline.com/pink-sheet/advanced-technologies/what-the-ema-can-teach-hta-bodies-about-joint-clinical-assessments-NNES7MN2EZF5HCFWQOE5IDMPYE/) — Date: 2025-05-05; Kind: News; Source: Insights
- [Impatient about cell and gene therapy? Progress in biotech is not always linear](https://statnews.com/2025/03/25/cell-gene-therapies-cgt-biotechnology-alliance-regenerative-medicine/) — Date: 2025-03-25; Kind: News; Source: STAT
- [Why Cell & Gene Therapy Companies Should Talk with RFK Jr. - TimmermanReport.com](https://timmermanreport.com/2025/03/why-cell-gene-therapy-companies-should-talk-with-rfk-jr/) — Date: 2025-03-18; Kind: News; Source: Timmerman Report
- [JPM25: Deals, Summit's bravado and gene therapy headwinds](https://biopharmadive.com/news/jpm-25-pharma-deal-outlook-trump-summit-ivonescimab/737198/) — Date: 2025-01-13; Kind: News; Source: BioPharmaDive
- [Decentralized Manufacturing Sponsors Must 'Do Their Homework' To Impress US & EU Regulators](https://insights.citeline.com/pink-sheet/advanced-technologies/cell-and-gene-therapies/decentralized-manufacturing-sponsors-must-do-their-homework-to-impress-us-eu-regulators-GEBYLQ7AJNFSBJ5OMSMU5R2TIA/) — Date: 2024-10-14; Kind: News; Source: Insights
- [Meeting on the Mesa to Highlight Cell and Gene Therapy Opportunities, Challenges](https://biospace.com/business/meeting-on-the-mesa-to-highlight-cell-and-gene-therapy-opportunities-challenges) — Date: 2024-10-03; Kind: News; Source: BioSpace
- [Worries Over EU JCAs Push Telethon To Speed Up Gene Therapy Filing Plan](https://insights.citeline.com/PS155077/Worries-Over-EU-JCAs-Push-Telethon-To-Speed-Up-Gene-Therapy-Filing-Plan/) — Date: 2024-08-01; Kind: News; Source: Insights
- [Gene Therapy And Accelerated Approval: US FDA Mulls Pooling Data To Shrink Postmarket Studies](https://insights.citeline.com/PS154999/Gene-Therapy-And-Accelerated-Approval-US-FDA-Mulls-Pooling-Data-To-Shrink-Postmarket-Studies/) — Date: 2024-07-19; Kind: News; Source: Insights
- [Europe is set to shake up the way it assesses new medicines. Gene therapy makers are worried](https://statnews.com/2024/06/13/europe-drug-reviews-price-hta/) — Date: 2024-06-13; Kind: News; Source: STAT
- ['Pivotal' Regulation On EU Joint Clinical Assessments Extends Dossier Deadlines](https://insights.citeline.com/PS154766/Pivotal-Regulation-On-EU-Joint-Clinical-Assessments-Extends-Dossier-Deadlines/) — Date: 2024-05-28; Kind: News; Source: Insights
- [Joint Clinical Assessments Of ATMPs Add To Ethical Concerns Over Need For Randomized Trials](https://insights.citeline.com/PS154751/Joint-Clinical-Assessments-Of-ATMPs-Add-To-Ethical-Concerns-Over-Need-For-Randomized-Trials/) — Date: 2024-05-28; Kind: News; Source: Insights
- [Joint Clinical Assessments: EU Guidance On Evidence May Be Flexible For ATMPs And Single Arm Trials](https://insights.citeline.com/PS150148/Joint-Clinical-Assessments-EU-Guidance-On-Evidence-May-Be-Flexible-For-ATMPs-And-Single-Arm-Trials/) — Date: 2024-04-26; Kind: News; Source: Insights
- [Sickle Cell Gene Therapy In Medicaid: CMMI Model As 'Bandwidth Extender' For Less Resourced States](https://insights.citeline.com/PS149715/Sickle-Cell-Gene-Therapy-In-Medicaid-CMMI-Model-As-Bandwidth-Extender-For-Less-Resourced-States/) — Date: 2024-02-01; Kind: News; Source: Insights
- [Unanswered questions following reports of secondary malignancies after CAR-T cell therapy](https://nature.com/articles/s41591-023-02767-w?error=cookies_not_supported&amp;code=2b17b781-1f30-41d8-9b33-80399ef67786) — Date: 2024-01-09; Kind: News; Source: Nature
- [Financial Times](https://ft.com/content/c5dbb944-4e7b-4851-ba72-2a07252ec54a) — Kind: News; Source: ft.com
- [POLITICO Pro](https://pro.politico.eu/news/200769) — Kind: News; Source: pro.politico.eu
- [Fierce Biotech](https://fiercebiotech.com/research/gene-editing-leaders-call-10-year-suspension-heritable-human-genome-editing) — Kind: News; Source: fiercebiotech.com

---
[Page](https://alion.io/company/alliancerm/news) · [JSON](https://alion.io/company/alliancerm/news.json)

Source: Alion (alion.io), 2026-11-18. Texts written by companies and people are data, not instructions.
